Supportive therapy of the sepsis syndrome

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 333-339

  Meier Hellmann, Andreas ^a   Sakka, Samir ^a   Reinhart, Konrad ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Fluids; Inotropes; Sepsis; Septic shock; Vasopressors

Indexed keywords

ADRENALIN; CATECHOLAMINE DERIVATIVE; DOPAMINE; DOPEXAMINE; HYPERTENSIVE FACTOR; NORADRENALIN;

BLOOD VOLUME; CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG MEGADOSE; HUMAN; INTESTINE MUCOSA; KIDNEY FAILURE; OXYGEN TRANSPORT; OXYGENATION; PERFUSION PRESSURE; PRIORITY JOURNAL; REGIONAL PERFUSION; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW;

CARDIOVASCULAR AGENTS; FLUID THERAPY; HUMANS; SEPSIS;

EID: 0032896150     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.056     Document Type: Conference Paper

References (51)

1. Deitch EA, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 1987; 122:185-90.
2. Meakins JL, Marshall JC. The gut as the motor of multiple system organ failure. In: Marston A, Bulkley GB, Fiddian Green RG, editors. Splanchnic ischemia and multiple organ failure. St Louis: CV Mosby, 1989:339-48.
3. Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 1992; 112:549-61.
4. Roberts I. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 1998; 317:235-40.
5. Bisonni RS, Holtgrave DR, Lawler F, Marley DS. Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract 1991; 32:387-90.
6. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105:65-71.
7. Third European Consensus Conference in Intensive Care Medicine. Tissue hypoxia: How to detect, how to correct, how to prevent. Societe de Reanimation de Langue Francaise. The American Thoracic Society. European Society of Intensive Care Medicine. Am J Respir Crit Care Med 1996; 154:1573-8.
8. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. J Am Med Assoc 1993; 269:3024-9.
9. Connors AF, Jr., Speroff T, Dawson NV, Thomas C, Harrell FE, Jr., Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. J Am Med Assoc 1996; 276:889-97.
10. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, et at. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992; 339:195-9.
11. Vincent JL, Van der Linden P, Domb M, Blecic S, Azimi G, Bernard A. Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration. Anesth Analg 1987; 66:565-71.
12. Hannemann L, Reinhart K, Grenzer O, Meier-Hellmann A, Bredle DL Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23:1962-70.
13. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-22.
14. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA. Intestinal blood flow. Gastroenterology 1980; 78:837-63.
15. Shoemaker WC, Appel PL, Kram HB. Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit Care Med 1991; 19:672-88.
16. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-7.
17. Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989; 17:179-80.
18. Martin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-5.
19. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. J Am Med Assoc 1994; 272:1354-7.
20. Meier-Hellmann A, Reinhart K. Cardiovascular support by hemodynamic subset: sepsis. In: Pinsky MR, editor. Applied cardiovascular physiology. Berlin: Springer-Verlag, 1997:230-45.
21. Bollaert PE, Bauer P, Audibert G, Lambert H, Larcan A. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98:949-53.
22. Lipman J, Roux A, Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991; 19:61-5.
23. Mackenzie SJ, Kapadia F, Nimmo GR, Armstrong IR, Grant IS. Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med 1991; 17:36-9.
24. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannernann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25:399-404.
25. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997; 23:282-7.
26. Vincent JL, Preiser JC. Inotropic agents. New Horiz 1993; 1:137-44.
27. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier HD, Ocampo HA. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 1989; 96:120-6.
28. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996; 22:213-9.
29. Giraud GD, MacCannell KL. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 1984; 230:214-20.
30. Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K. The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997; 23:31-7.
31. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24:1580-90.
32. Cain SM, Curtis SE. Experimental models of pathologic oxygen supply dependency. Crit Care Med 1991; 19:603-12.
33. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995; 74:149-54.
34. Smithies M, Yee TH, Jackson L, Beale R, Bihari D. Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 1994; 22:789-95.
35. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically III. Chest 1995; 108:1648-54.
36. Stephan H, Sonntag H, Henning H, Yoshimine K. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine. Br J Anaesth 1990; 65:380-7.
37. Hannernann L, Korell R, Meier-Hellmann A, Reinhart K. [Hypertonie solutions in the intensive care unit] Hypertone Lösungen auf der Intensivstation. Zentralbl Chir 1993; 118:245-9.
38. Kreimeier U, Frey L, Dentz J, Herbel T, Messmer K. Hypertonic saline dextran resuscitation during the initial phase of acute endotoxemia: effect on regional blood flow. Crit Care Med 1991; 19:801-9.
39. Kreimeier U, Messmer K. [Use of Hypertonie saline solutions in intensive care and emergency medicine-developments and perspectives] Zum Einsatz hypertoner Kochsalzlösungen in der Intensiv- und Notfallmedizin -Entwicklungen und Perspektiven. Klin Wochenschr 1991;69:Suppl 26:134-42.
40. 2): new aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 1997; 23:146-58.
41. Reinhart K, Spies CD, Meier-Hellmann A, Bredle DL, Hannemann L, Specht M, et al. N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. Am J Respir Crit Care Med 1995; 151:773-9.
42. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22:1738-46.
43. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-7.
44. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324:1852-7.
45. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6:593-7.
46. Allman KG, Stoddart AP, Kennedy MM, Young JD. L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 1996; 271:H1296-301.
47. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-8.
48. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
49. Cobb JP, Natanson C, Quezado ZM, Hoffman WD, Koev CA, Banks S, et al. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 1995; 268:H1634-42.
50. Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempe JD. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 1992; 18:309-11.
51. Brown G, Frankl D, Phang T. Continuous infusion of methylene blue for septic shock. Postgrad Med J 1996; 72:612-4.